Home/Filings/4/0001673232-26-000004
4//SEC Filing

BENKOWITZ MICHAEL 4

Accession 0001673232-26-000004

CIK 0001082554other

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:31 PM ET

Size

38.5 KB

Accession

0001673232-26-000004

Insider Transaction Report

Form 4
Period: 2026-01-05
BENKOWITZ MICHAEL
PRESIDENT AND COO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-05$117.76/sh+14,625$1,722,24014,625 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$480.68/sh697$335,03513,928 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$481.86/sh1,657$798,44612,271 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$482.72/sh873$421,41411,398 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$483.80/sh697$337,21210,701 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$485.00/sh1,169$566,9599,532 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$486.05/sh1,669$811,2177,863 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$487.40/sh856$417,2187,007 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$488.38/sh1,189$580,6795,818 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$489.49/sh677$331,3855,141 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$490.11/sh1,659$813,0943,482 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$491.35/sh1,201$590,1112,281 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$492.44/sh1,110$546,6131,171 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$493.47/sh374$184,559797 total(indirect: By Trust)
  • Sale

    Common Stock

    2026-01-05$494.27/sh797$393,9350 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Options

    2026-01-0514,62597,125 total(indirect: By Trust)
    Exercise: $117.76From: 2020-03-15Exp: 2027-03-15Common Stock (14,625 underlying)
Holdings
  • Common Stock

    2,648
Footnotes (16)
  • [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on June 3, 2025.
  • [F10]This transaction was executed in multiple trades at prices ranging from $487.90 to $488.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F11]This transaction was executed in multiple trades at prices ranging from $488.90 to $489.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F12]This transaction was executed in multiple trades at prices ranging from $489.90 to $490.885. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F13]This transaction was executed in multiple trades at prices ranging from $490.90 to $491.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F14]This transaction was executed in multiple trades at prices ranging from $491.91 to $492.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F15]This transaction was executed in multiple trades at prices ranging from $492.96 to $493.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F16]This transaction was executed in multiple trades at prices ranging from $493.99 to $494.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]Reflects the exercise of options, and sale of the resulting shares of common stock, held in a trust beneficially owned by the Reporting Person, of which the Reporting Person is a beneficiary, and as to which the Reporting Person and his spouse are co-trustees and have shared investment and voting power.
  • [F3]This transaction was executed in multiple trades at prices ranging from $480.32 to $481.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F4]This transaction was executed in multiple trades at prices ranging from $481.32 to $482.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F5]This transaction was executed in multiple trades at prices ranging from $482.34 to $483.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F6]This transaction was executed in multiple trades at prices ranging from $483.47 to $484.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F7]This transaction was executed in multiple trades at prices ranging from $484.54 to $485.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F8]This transaction was executed in multiple trades at prices ranging from $485.58 to $486.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F9]This transaction was executed in multiple trades at prices ranging from $486.79 to $487.78. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

UNITED THERAPEUTICS Corp

CIK 0001082554

Entity typeother

Related Parties

1
  • filerCIK 0001673232

Filing Metadata

Form type
4
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:31 PM ET
Size
38.5 KB